Tag: FDA’s flexibility in assessing smoking cessation therapies

news-17102024-083935

FDA Shows Flexibility in Evaluating Smoking Cessation Treatments for Public Meeting

The Food and Drug Administration (FDA) is making changes to how it evaluates new treatments to help people quit smoking. This week, the FDA, along with the National Institutes of Health, published a perspective...